Literature DB >> 8880483

Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.

N Tsumura1, U Emre, P Roblin, M R Hammerschlag.   

Abstract

We examined the effect of hydrocortisone succinate on the growth of three isolates of Chlamydia pneumoniae in vitro. There was a significant increase in the number of inclusions seen in two of the C. pneumoniae strains in the presence of hydrocortisone. There was no significant increase in the number of inclusions with various concentrations of hydrocortisone over time. The addition of hydrocortisone did not affect the in vitro activities of azithromycin, erythromycin, and doxycycline against C. pneumoniae.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8880483      PMCID： PMC229273          DOI： 10.1128/jcm.34.10.2379-2381.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Infections caused by Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

4.  The association of Chlamydia pneumoniae infection and reactive airway disease in children.

Authors:  U Emre; P M Roblin; M Gelling; W Dumornay; M Rao; M R Hammerschlag; J Schachter
Journal:  Arch Pediatr Adolesc Med       Date:  1994-07

5.  Effects of corticosteroids and cyclophosphamide on a mouse model of Chlamydia trachomatis pneumonitis.

Authors:  R S Stephens; W J Chen; C C Kuo
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Reactivation of Chlamydia trachomatis lung infection in mice by cortisone.

Authors:  Y S Yang; C C Kuo; W J Chen
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Effect of cortisol on the growth of Chlamydia trachomatis in McCoy cells.

Authors:  A C Bushell; D Hobson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.

Authors:  R Malinverni; C C Kuo; L A Campbell; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.

Authors:  R J North; A A Izzo
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307
View more
  4 in total

1.  Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Authors:  Shusaku Haranaga; Hideaki Ikejima; Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

3.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

4.  Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.

Authors:  Seoung-Ju Park; Yong-Chul Lee; Yang-Keun Rhee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.